Quantcast

Latest heart transplant Stories

2010-03-14 14:31:51

The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a Henry Ford Hospital study. Researchers say the 25 patients in the study did not experience adverse side effects such as abnormally low blood pressure or slow heart beat when regadenoson was used during the stress test. Additionally, patients showed no signs of heart block, a condition in which the signal from the...

2010-02-12 16:27:00

HOUSTON, Feb. 12 /PRNewswire/ -- The wait is over for 16-year-old Francesco "Frank" De Santiago. On January 29, De Santiago received a donor heart in a successful nine-hour transplant operation at Texas Children's Heart Center. De Santiago made medical history last October for being the first child ever discharged from a pediatric hospital with an implanted mechanical heart pump, or intracorporeal ventricular assist device (VAD). Until then, pediatric patients with mechanical heart...

2009-12-21 22:35:49

Many heart transplant patients develop multiple skin cancers, with increased risk for some skin cancers among patients with other cancers and with increasing age, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. "Solid organ transplant recipients are at increased risk for skin cancers," the authors write as background information in the article. "Incidence, tumor burden and risk factors for skin cancer are well documented in renal...

0f2d42961afe83d567b058ece93069c01
2009-11-17 15:20:33

A new type of heart pump significantly improves survival in people with severe heart failure, according to a study presented Tuesday at an American Heart Association conference and published by the New England Journal of Medicine. The device, called the HeartMate II, is implanted next to a patient's own heart to help it pump blood, and could become the first such device to be widely used as a permanent treatment for the heart failure. A study comparing the HeartMate II to a conventional pump...

2009-11-10 12:35:00

SACRAMENTO, Calif., Nov. 10 /PRNewswire/ -- The Joint Commission has awarded Sutter Medical Center, Sacramento the Ventricular Assist Device/Destination Therapy certification, allowing the Sacramento region's only heart transplant program to implant left ventricular assist devices (LVADs) as permanent therapy and not just as bridges to transplant. Sutter Medical Center, Sacramento is the only hospital in Northern California to have this certification. Two hospitals in the Bay Area had the...

2009-10-21 17:40:00

SACRAMENTO, Calif., Oct. 21 /PRNewswire/ -- Larry Clymer's heart was just plum wearing out. The 60-year-old Rocklin resident needed a heart transplant, and a temporary machine was implanted in his abdomen to keep his heart beating until the right heart was identified. Then, in February, Clymer received more devastating news. The federal Centers for Medicare and Medicaid Services (CMS) canceled Sutter Medical Center, Sacramento's contract for its Heart Transplant Program. That meant...

2009-10-14 13:46:00

LOMA LINDA, Calif., Oct. 14 /PRNewswire-USNewswire/ -- Monday, October 26, marks the 25-year anniversary of the first neonatal cross-species heart transplant in history. Dr. Leonard Bailey and a team of doctors at Loma Linda University Medical Center transplanted the heart of a baboon into an infant, born with uniformly lethal heart disease and known to the world as "Baby Fae," on October 26, 1984. Though she only lived 20 days following the operation, her legacy has extended the life of...

2009-05-28 08:00:00

DEERFIELD, Ill., May 28 /PRNewswire/ -- The Food and Drug Administration (FDA) has granted Astellas Pharma US, Inc. approval for the use of Prograf(R) (tacrolimus) in conjunction with mycophenolate mofetil (MMF) for the prevention of organ rejection in kidney transplant recipients. Prograf is a cornerstone therapy for preventing transplant rejection in liver, kidney and heart transplant recipients. The approval came on May 19, 2009 in response to a Supplemental New Drug Application (sNDA)...

2009-04-02 20:25:37

Patients with severe heart failure can be bridged to eventual transplant by a new, smaller and lighter implantable heart pump, according to a just-completed study of the device. Results of this third-generation heart assist device were reported at the 58th annual meeting of the American College of Cardiology on March 30.The device, called a left ventricular assist device (LVAD), is the latest generation of heart assist devices. The LVAD was tested at five main sites: Washington University...

2009-03-13 15:46:00

Hospital's Bluhm Cardiovascular Institute achieves milestone outcomes for heart transplant CHICAGO, March 13 /PRNewswire-USNewswire/ -- Newly released data from the United Network of Organ Sharing (UNOS) shows that in 2008 Northwestern Memorial Hospital's heart transplant program achieved the largest volumes and top-rated outcomes in Illinois -- a ranking that places the program among the top 20 heart transplant programs nationally. "We are very proud of the collaborations and diligent...


Latest heart transplant Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'